Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if estradiol augmentation of luteinizing hormone
(LH) secretion secretion (primary endpoint) and follicle-stimulating hormone (FSH) secretion
(secondary endpoint) is reduced in adult women with polycystic ovary syndrome.